IGF1 and breast carcinoma: The aim of this study was to estimate risk ratios for sex-steroid hormone biomarkers in relation to postmenopausal breast cancer in a case-cohort of postmenopausal women within the Melbourne Collaborative Cohort Study (MCCS), while accounting for other biomarkers from the insulin/IGF-signaling and inflammatory pathways.